Request Demo
Last update 20 Mar 2025
TROP2-CAR-NK Cells(Bellicum Pharmaceuticals)
Last update 20 Mar 2025
Overview
Basic Info
Drug Type CAR-NK |
Synonyms- |
Target |
Action modulators |
Mechanism Trop-2 modulators(Tumor-associated calcium signal transducer 2 modulators), Immunologic cytotoxicity, Natural killer cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with TROP2-CAR-NK Cells(Bellicum Pharmaceuticals)NCT06358430
Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)
NCT06066424
Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
100 Clinical Results associated with TROP2-CAR-NK Cells(Bellicum Pharmaceuticals)
Login to view more data
100 Translational Medicine associated with TROP2-CAR-NK Cells(Bellicum Pharmaceuticals)
Login to view more data
100 Patents (Medical) associated with TROP2-CAR-NK Cells(Bellicum Pharmaceuticals)
Login to view more data
100 Deals associated with TROP2-CAR-NK Cells(Bellicum Pharmaceuticals)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Phase 1 | United States | 02 Dec 2024 | |
| HER2-negative breast cancer | Phase 1 | United States | 24 Oct 2023 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 1 | United States | 24 Oct 2023 | |
| Non-Small Cell Lung Cancer | Phase 1 | United States | 24 Oct 2023 | |
| Triple Negative Breast Cancer | Phase 1 | United States | 24 Oct 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free